<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04122677</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A03207-48</org_study_id>
    <nct_id>NCT04122677</nct_id>
  </id_info>
  <brief_title>Performance and Safety of the Polylactic Interference Screw Used in Anterior Cruciate Ligament Reconstructions</brief_title>
  <official_title>Performance and Safety of the Polylactic Interference Screw Used in Anterior Cruciate Ligament Reconstructions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biomatlante</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ATLANSTAT</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Biomatlante</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The evaluation of the clinical data has demonstrated the conformity of the Polylactic
      Interference Screw (PIS), with the relevant essential requirements for its use in orthopaedic
      applications. The Polylactic Interference Screws are intended for tibial and femoral
      ligament/graft fixation in the case or Anterior Cruciate Ligament (ACL) reconstructions. It
      has been concluded that the risks associated with the use of the device are acceptable when
      weighted against the benefits to the patients. In order to improve the clinical data on the
      PIS, the manufacturer, Biomatlante, decided to assess that the performance and safety of the
      device are maintained until the reaching of its intended use. In this objective, the goal of
      this study will be to observe the following parameters:

      Objective IKDC score (clinical evaluation) Subjective IKDS score (functional evaluation)
      Safety (report of any adverse event) Follow-up of the patient's recovery
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2019</start_date>
  <completion_date type="Anticipated">October 5, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 5, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of the objective International Knee Documentation Committee score before and after surgery</measure>
    <time_frame>4 months before surgery / 7 months post-surgery</time_frame>
    <description>Record of the objective International Knee Documentation Committee score (A = normal, B = almost normal, C = abnormal or D = very abnormal)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of the subjective International Knee Documentation Committee score before and after surgery</measure>
    <time_frame>4 months before surgery / 7 months post-surgery</time_frame>
    <description>Record of the subjective International Knee Documentation Committee score (from 1 to 100 where 100 is the best result)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number and precise description of any adverse event during the follow-up</measure>
    <time_frame>Before surgery until 7 months post-surgery</time_frame>
    <description>Record and description of any adverse event during the follow-up that reflects the safety of the Polylactic Interference Screw</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the patients recovery</measure>
    <time_frame>2 months post-surgery</time_frame>
    <description>Record of specific items of the Objective International Knee Documentation Committee score reflecting the patients recovery</description>
  </secondary_outcome>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Knee Ligament Injury</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Anterior Cruciate Ligament Reconstruction</intervention_name>
    <description>Reconstruction of the Anterior Cruciate Ligament using an interference screw.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is considered as all the patients included in the study that meet the
        inclusion and exclusion criteria.

        The study population is composed of 56 patients according to the protocol.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute or chronic Anterior Cruciate Ligament deficiency with complete or partial lesion
             of the anteromedial bundle requiring primary reconstruction of the Anterior Cruciate
             Ligament with hamstring tendons

          -  Males or females aged from 18 to 60 years

          -  No history of surgery on the affected knee

          -  Patients not under guardianship or judicial protection

          -  Signature of non opposition form (consent of the patient

        Exclusion Criteria:

          -  History of ligament, meniscal surgery or fracture of the affected knee

          -  Pregnancy of breastfeeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>François-Xavier FV VERDOT, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre ORTHEO</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura LP PAGNUCCO, Master II</last_name>
    <phone>0228020009</phone>
    <email>laurapagnucco@biomatlante.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nancy NT TRICHEREAU, Master II</last_name>
    <phone>0228020009</phone>
    <email>nancytrichereau@biomatlante.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre ORTHEO</name>
      <address>
        <city>Saint-Étienne</city>
        <state>Loire</state>
        <zip>42100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François-Xavier FV VERDOT, M.D.</last_name>
      <phone>0477490986</phone>
      <email>fxverdot@ortheo.org</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 30, 2019</study_first_submitted>
  <study_first_submitted_qc>October 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2019</study_first_posted>
  <last_update_submitted>January 14, 2020</last_update_submitted>
  <last_update_submitted_qc>January 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Knee Ligament Injury</keyword>
  <keyword>Anterior Cruciate Ligament Rupture</keyword>
  <keyword>Anterior Cruciate Ligament Reconstruction</keyword>
  <keyword>Knee Ligament Rupture</keyword>
  <keyword>Knee Ligament Reconstruction</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 5, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/77/NCT04122677/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

